NYSE - Delayed Quote USD

Elevance Health, Inc. (ELV)

534.63 -4.14 (-0.77%)
At close: May 14 at 4:00 PM EDT
523.10 -11.53 (-2.16%)
After hours: May 14 at 7:34 PM EDT
Loading Chart for ELV
DELL
  • Previous Close 538.77
  • Open 539.67
  • Bid 523.10 x 800
  • Ask 534.95 x 800
  • Day's Range 533.54 - 540.22
  • 52 Week Range 412.00 - 543.13
  • Volume 468,446
  • Avg. Volume 971,050
  • Market Cap (intraday) 124.258B
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) 20.17
  • EPS (TTM) 26.51
  • Earnings Date Jul 17, 2024 - Jul 22, 2024
  • Forward Dividend & Yield 6.52 (1.21%)
  • Ex-Dividend Date Jun 10, 2024
  • 1y Target Est 605.45

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

www.elevancehealth.com

104,900

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ELV

Performance Overview: ELV

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ELV
13.74%
S&P 500
10.00%

1-Year Return

ELV
18.38%
S&P 500
27.22%

3-Year Return

ELV
40.04%
S&P 500
27.58%

5-Year Return

ELV
117.52%
S&P 500
86.59%

Compare To: ELV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ELV

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    125.22B

  • Enterprise Value

    145.44B

  • Trailing P/E

    20.32

  • Forward P/E

    14.47

  • PEG Ratio (5yr expected)

    0.90

  • Price/Sales (ttm)

    0.74

  • Price/Book (mrq)

    3.08

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.64%

  • Return on Assets (ttm)

    5.78%

  • Return on Equity (ttm)

    15.95%

  • Revenue (ttm)

    171.75B

  • Net Income Avi to Common (ttm)

    6.24B

  • Diluted EPS (ttm)

    26.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.27B

  • Total Debt/Equity (mrq)

    64.97%

  • Levered Free Cash Flow (ttm)

    -261.12M

Research Analysis: ELV

Company Insights: ELV

Research Reports: ELV

People Also Watch